Moffitt Cancer Center

As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt employs some of the best and brightest minds from around the world. Moffitt is the top cancer hospital in Florida according to U.S. News & World Report and has been nationally ranked since 1999.

This symposium is an opportunity for patients and caregivers to learn about melanoma from medical professionals and fellow patients, caregivers, and survivors. This event is FREE and open to all and will be presented in-person and virtually. The maximum number for in-person attendees is 40 people.

Date: Saturday – March 4, 2023
Time:  8:30 AM (ET)|7:30 AM (CT) |6:30 AM (MT) | 5:30 AM (PT)
(double-check your local time with this time zone converter)
Location: Moffitt Cancer Center, Richard M. Schulze Family Foundation Outpatient Center at McKinley Campus (10920 McKinley Dr., Tampa, FL 33612). The Moffitt’s McKinley campus entrance is the covered walkway just after exiting the parking garage near the stairs and elevators. Please follow the breezeway until you see a registration table and the double glass doors. Volunteers will be present to assist guests.

Parking Instructions: Free parking in the Moffitt McKinley Parking Garage will be available on the day of the event.

  • As you arrive Saturday morning, there will be self-parking available in the on-campus parking garage.
  • Once you have turned into the main entrance of campus off McKinley Dr., please follow the road to the stop sign.
  • You will then take a right-hand turn and enter the parking garage on your left. Please self-park on floors 1-2.


Presentadores y temas

8:30 AM ET

Registration & Continental Breakfast For In-Person Attendees

9:00 AM ET

Welcome and Opening Remarks
Vernon Sondak, MD
Chair, Department of Cutaneous Oncology
Moffitt Cancer Center

9:10 AM ET

Understanding your Pathology Report and the Implications for Treatment 
Jane Messina, MD
Vice Chair, Anatomic Pathology
Moffitt Cancer Center

9:30 AM ET

Update on Surgery and Predictive Testing for Early Stage Melanoma
Vernon Sondak, MD
Chair, Department of Cutaneous Oncology
Moffitt Cancer Center

9:50 AM ET

Adjuvant and Neoadjuvant Therapy for Stage II and III Melanoma
Ahmad Tarhini, MD, PhD
Director, Cutaneous Clinical and Translational Research
Moffitt Cancer Center

10:10 AM ET


10:35 AM ET


10:45 AM ET

What’s the Best Approach to Treating Stage IV Melanoma?
Lilit Karapetyan, MD, MS, FACP
Moffitt Cancer Center

11:05 AM ET

The Current Status and Future of TIL Therapy for Melanoma
Amod Sarnaik, MD
Moffitt Cancer Center

11:25 AM ET

AIM at Melanoma Patient Resources
Ann Garst Taylor
Director of Community Engagement

11:30 AM ET


Registration Form